Pn Ivf Access Trading Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 0.60 M
as on 07-07-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 179445.05%
(FY 2022)
- Profit -45.40%
(FY 2022)
- Ebitda -77.87%
(FY 2022)
- Net Worth 69.39%
(FY 2022)
- Total Assets 198.43%
(FY 2022)
About Pn Ivf Access Trading
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Nikhil Rajmohan, Kanika Mayar, and Naresh Rao serve as directors at the Company.
- CIN/LLPIN
U85190KA2020FTC133864
- Company No.
133864
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
22 Apr 2020
- Date of AGM
04 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pn Ivf Access Trading?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Rajmohan  | Director | 25-May-2020 | Current |
| Kanika Mayar | Nominee Director | 12-Jan-2021 | Current |
| Naresh Rao | Director | 22-Apr-2020 | Current |
Financial Performance and Corporate Structure Insights of Pn Ivf Access Trading.
Pn Ivf Access Trading Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 179445.05% increase. The company also saw a substantial fall in profitability, with a 45.4% decrease in profit. The company's net worth Soared by an impressive increase of 69.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pn Ivf Access Trading?
In 2021, Pn Ivf Access Trading had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pn Ivf Access Private LimitedActive 4 years 9 monthsNikhil Rajmohan, Kanika Mayar and 1 more are mutual person
Vertex Ventures Sea Management India Private LimitedActive 7 years 4 monthsKanika Mayar is a mutual person
Bendable Technology Solutions Private LimitedActive 6 years 6 monthsKanika Mayar is a mutual person
Cgil Retail Trading Private LimitedActive 4 years 2 monthsNikhil Rajmohan and Naresh Rao are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pn Ivf Access Trading?
Unlock and access historical data on people associated with Pn Ivf Access Trading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pn Ivf Access Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pn Ivf Access Trading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
